Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06629259 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Guanfacine for Alcohol Use Disorder (AUD)

StatusRecruiting
PhasePhase 2
Started2025-10-03
View on ClinicalTrials.gov ↗

Amendment history

2026-05-07
Study Status v4
Start date2025-09-01→2025-10-03
2025-09-16
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-08-01→confirmed 2025-09-01
Study sitesdetails revised at 2 of 2 sites
2025-06-09
Study Status, Contacts/Locations v2
Start date2025-03-01→2025-08-01
2024-12-18
Study Status, Study Description, Outcome Measures, Eligibility, Contacts/Locations v1
Completion date2029-09-30→2029-09-07
Start date2024-12-01→2025-03-01
Study sites1→2
Eligibility criteria+59 characters
[...] e hypotensive with sitting blood pressure below 100/50 mmHG have bradycardia with a sitting heart rate (HR) of <60 bpm show EKG evidence of any clinically significant conduction a [...]
Secondary endpointsdetails revised at 6 of 6 entries
Study description-10 characters
This is a five year study to examine the efficacy of guanfacine extended releas [...]
2024-10-03
Original filing
The investigators assess whether guanfacine extended release (GXR; 3mg/d) compared with placebo (PBO) will attenuate drinking and drinking-related factors in N=200 men and women with Alcohol Use Disorder (AUD) across 12-weeks.
Trial Details
NCT Number NCT06629259
Lead Sponsor Indiana University
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions Alcohol Use Disorder
Enrollment 200 participants
Start Date 2025-10-03
Primary Completion 2029-08-31 (estimated)
Study Completion 2029-09-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-11